p53 gene with retrovirus vector for gene therapy: Began Phase I trial, in which accessible tumor will be removed and the agent will be injected into the remaini

Introgen Therapeutics Inc., Collegeville, Penn. RPR Gencell (Rhone-Poulenc Rorer) Product: p53 gene with retrovirus vector for gene therapy Indication: Non-small cell lung cancer Status: Began Phase ...